Abstract
Depression, a frequent concomitant disorder in multiple sclerosis (MS), can impact MS treatment adherence and quality of life. Depression screening in MS care settings may facilitate needed intervention when providers are responsive to screening findings. This study sought to examine the relationship between depression screening results and provider depression treatment recommendations documented in the medical records of 283 patients receiving care in an integrated MS clinic. Forty-six percent of patients screening positive for depression received a treatment recommendation; females, those with past mental health diagnoses, on psychotropic medications, and those with higher symptom severity were more likely to receive a treatment recommendation. On subsequent screenings, patients reported fewer depressive symptoms regardless of whether a formal treatment recommendation was documented. These findings suggest that while depression screening does lead to depression related intervention in many cases, more research is necessary to determine who is most likely to benefit and under what conditions.
Similar content being viewed by others
References
AHA Science Advisory. (2008). Depression and coronary heart disease: Recommendations for screening referral and treatment. A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation, 118, 1768–1775.
Alschuler, K., Hoodin, F., & Byrd, M. (2008). The need for integrating behavioral care in a college health center. Health Psychology, 27, 388–393.
American Psychological Association Government Relations Staff. (2009). Fully integrate mental health services in health care reform. Retrieved from http://www.apapracticecentral.org/advocacy/medical/fully-integrate-mental.aspx.
Beck, A. T., Steer, R. A., & Brown, G. K. (2000). BDI-FS for Medical Patients: Manual. San Antonio, TX: Psychological Corporation.
Benedict, R. H., Fishman, I., McClellan, M. M., Bakshi, R., & Weinstock-Guttman, B. (2003). Validity of the beck depression inventory-fast screen in multiple sclerosis. Multiple Sclerosis, 9, 393–396.
Bluestein, D., & Cubic, B. A. (2009). Psychologists and primary care physicians: A training model for creating collaborative relationships. Journal of Clinical Psychology in Medical Settings, 16, 101–112.
Byatt, N., Moore Simas, T. A., Lundquist, R. S., Johnson, J. V., & Ziedonas, D. M. (2012). Strategies for improving perinatal depression treatment in North American outpatient obstetric settings. Journal of Psychosomatic Obstetrics & Gynecology, 33, 143–161.
Centers for Medicare and Medicaid Services. (2011). Decision memo for screening for depression in adults. Retrieved from http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=251.
Chwastiak, L., Gibbons, L. E., Ehde, D. M., Sullivan, M., Bowen, J. D., Bombardier, C. H., et al. (2005). Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. Journal of Psychosomatic Research, 59, 291–298.
Committee on Obstetric Practice. (2010). Committee opinion no. 453: Screening for depression before and after pregnancy. Obstetrics and Gynecology, 115, 394–395.
Dahl, O., Stordal, E., Lydersen, S., & Midgard, R. (2009). Anxiety and depression in multiple sclerosis: A comparative population-based study in Nord-Trøndelag County, Norway. Multiple Sclerosis, 15, 1495–1501.
Egede, L. E. (2007). Failure to recognize depression in primary care: Issues and challenges. Journal of General Internal Medicine, 22, 701–703.
Galeazzi, G. M., Ferrari, S., Giaroli, G., Mackinnon, A., Merelli, E., Motti, L., et al. (2005). Psychiatric disorders and depression in multiple sclerosis outpatients: Impact of disability and interferon beta therapy. Neurological Sciences, 26, 255–262.
Gearing, R. E., Mian, I. A., Barber, J., & Ickowicz, A. (2006). A methodology for conducting retrospective chart review research in child and adolescent psychiatry. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 15, 126–134.
Gilbody, S., Whitty, P., Grimshaw, J., & Thomas, R. (2003). Educational and organizational interventions to improve the management of depression in primary care: A systematic review. Journal of the American Medical Association, 289, 3145–3151.
Goldman Consensus Group. (2005). The Goldman Consensus statement on depression in multiple sclerosis. Multiple Sclerosis, 11, 328–337.
Hickie, I. B., Davenport, T. A., & Ricci, C. S. (2002). Screening for depression in general practice and related medical settings. Medical Journal of Australia, 177, S111–S116.
Hoodin, F., Zhao, L., Carey, J., Levine, J. E., & Kitko, C. (2013). Impact of psychological screening on routine outpatient care of hematopoietic stem cell transplantation survivors. Biology of Blood and Marrow Transplantation, 19, 1493–1497.
Kush, R. F. (2001). Primary care and clinical psychology: Assessment strategies in medical settings. Journal of Clinical Psychology in Medical Settings, 8, 219–228.
Liu, S., Lu, R., & Lee, M. (2008). Non-psychiatric physicians’ knowledge, attitudes, and behavior toward depression. Journal of the Formosan Medical Association, 107(12), 921–931.
Milgrom, J., Mendelsohn, J., & Gemmill, A. W. (2011). Does postnatal depression screening work? Throwing out the bathwater, keeping the baby. Journal of Affective Disorders, 132, 301–310.
Mitchell, A. J., Benito-Leon, J., Gonzalez, J. M., & Rivera-Navarro, J. (2005). Quality of life and its assessment in multiple sclerosis: Integrating physical and psychological components of wellbeing. The Lancet Neurology, 4, 556–566.
Mohr, D. C., Hart, S. L., Julian, L., & Tasch, E. S. (2007). Screening for depression among patients with multiple sclerosis: Two questions may be enough. Multiple Sclerosis, 13, 215–219.
Mohr, D. C., Likosky, W., Dwyer, P., Van Der Wende, J., Boudewyn, A. C., & Goodkin, D. E. (1999). Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis. Archives of Neurology, 56, 1263–1265.
National Institute for Health & Clinical Excellence. (2010). Depression: The NICE Guideline on the Treatment and Management of Depression in Adults (Updated ed.). Leceister and London, England: British Psychological Society and the Royal College of Psychiatrists.
Palmer, S. C., & Coyne, J. C. (2003). Screening for depression in medical care: Pitfalls, alternatives, and revised priorities. Journal of Psychosomatic Research, 54, 279–287.
Patten, S. B., Berzins, S., & Metz, L. M. (2010). Challenges in screening for depression in multiple sclerosis. Multiple Sclerosis, 16, 1406–1411.
Patten, S. B., Williams, J. V. A., & Metz, L. M. (2008). Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis. Multiple Sclerosis, 14, 406–411.
Pignone, M. P., Gaynes, B. N., Rushton, J. L., Burchell, C. M., Orleans, C. T., Mulrow, C. D., et al. (2002). Screening for depression in adults: A summary of the evidence. Annals of Internal Medicine, 136, 765–776.
Sederer, L. I., Petit, J. R., Paone, D., Ramos, S., Rubin, J., & Christman, M. (2007). Changing the Landscape: Depression Screening and Management in Primary Care. Washington, DC: Joint Center for Political and Economic Studies Health Policy Institute.
Siegert, R. J., & Abernethy, D. A. (2005). Depression in multiple sclerosis: A review. Journal of Neurology, Neurosurgery and Psychiatry, 76, 469–475.
Stepleman, L. M., Jump, R., Shelton, S. F., & Hughes, M. D. (2009). Psychological consultation services at a multiple sclerosis clinic. International Journal of MS Care, 11, 180–186.
Thombs, B. D., Coyne, J. C., Cuijpers, P., de Jonge, P., Gilbody, S., Ioannidis, J. P. A…Ziegelstein, R. C. (2012). Rethinking recommendations for screening for depression in primary care. Canadian Medical Association Journal, 184, 413–418.
Turner, A. P., Martin C., Williams, R. M., Goudreau, K., Bowen, J. D., Hatzakis, M…Haselkorn, J. K. (2006). Exploring educational needs of multiple sclerosis care providers: Results of a care-provider survey. Journal of Rehabilitation Research and Development, 43, 25–34.
U.S. Preventive Services Task Force. (2009). Screening for depression in adults: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 151, 784–792.
Valenstein, M., Vijan, S., Zeber, J., Boehm, K., & Buttar, A. (2001). The cost-utility of screening for depression in primary care. Annals of Internal Medicine, 134, 345–360.
Wallin, M. T., Wilken, J. A., Turner, A. P., Williams, R. M., & Kane, R. (2006). Depression and multiple sclerosis: Review of a lethal combination. Journal of Rehabilitation Research and Development, 43, 45–62.
Zdilar, D., Franco-Bronson, K., Buchler, N., Locala, J. A., & Younossi, Z. M. (2000). Hepatitis C, interferon alfa, and depression. Hepatology, 31, 1207–1211.
Conflict of Interest
Lara Stepleman, Lauren Penwell-Waines, Michael Rollock, Rhonda Casillas, Tricia Brands, Jeff Campbell, Brittany Ange, and Jennifer Waller declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation of the Medical College of Georgia whose Institutional Review Board approved the research and with the Helsinki Declaration of 1975, as revised in 2000. No animal or human studies were carried out by the authors for this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stepleman, L.M., Penwell-Waines, L.M., Rollock, M. et al. Routine Depression Screening in an MS Clinic and Its Association with Provider Treatment Recommendations and Related Treatment Outcome. J Clin Psychol Med Settings 21, 347–355 (2014). https://doi.org/10.1007/s10880-014-9409-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10880-014-9409-0